Trial
NCT02439788
3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Baylor College of Medicine
Collaborators
Center for Cell and Gene Therapy, Baylor College of Medicine; Alex's Lemonade Stand Foundation
Condition
Neuroblastoma
Intervention
cyclophosphamide
Why stopped
Based on newly available preclinical data we changed the CAR construct to a more effective version and will now study that product on a different protocol.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-14